Save the date: HU CFAR Virtual Grand Rounds with Dr. Myron Cohen "Prevention of HIV and Other Emerging Infections: Things We Have Learned Over 40 Years"


Wednesday, December 16, 2020, 12:00pm to 1:00pm


Zoom Webinar

Registration Link
Myron S. Cohen, MD

Dr. Cohen is the Yeargan-Bate Eminent Professor of Medicine, Microbiology and Immunology and Epidemiology at the University of North Carolina (UNC) at Chapel Hill. He serves as the associate vice chancellor for global health at the university, and director for the Institute for Global Health & Infectious Diseases (IGHID). Dr. Cohen received the Distinguished Alumnus Award from Rush Medical College in 2000, the lifetime achievement award from the American Sexually Transmitted Diseases Association and the O. Max Gardner Award, the highest honor in the University of North Carolina System. In 2013, Dr. Cohen received the Smadel Award from the Infectious Disease Society in recognition of his work in public health and the Award for Science from the State of North Carolina, its highest civilian honor. He is a fellow of the American College of Physicians and the Infectious Disease Society of America, and a member of the National Academy of Medicine, the American Society of Clinical Investigation and the American Association of Physicians. Dr. Cohen serves as the co-principal investigator of the NIH HIV Prevention Trials Network (HPTN). Dr. Cohen has focused on the transmission and prevention of transmission of HIV. Dr. Cohen is the architect and Principal Investigator of the multinational HPTN 052 trial, which demonstrated that antiretroviral treatment of people with HIV infection, prevents the sexual transmission of the virus. Science Magazine recognized this work as the “Breakthrough of the Year” in 2011. Most recently, Dr. Cohen has played an active role in development of the COVID-19 prevention activities. He serves on the NIH ACTIV Committee, a public-private partnership to organize COVID-19 research. He is a member of the Executive Committee of newly formed NIAID COVID Prevention Network (CoVPN). In this capacity, Dr. Cohen his leading research on the use of monoclonal antibodies for the prevention and early treatment of COVID-19.

Kathryn Stephenson, MD and Boris Juelg, MD

See also: Symposia